Institutional culture changes over an eight-year period made infection prevention and control “everyone’s business,” researchers say. Active surveillance was a major driver.
Three senior executives at scope maker Olympus Corp., which is under federal investigation for its role in superbug outbreaks, repeatedly invoked their Fifth Amendment right against self-incrimination when questioned recently about internal company emails.
The challenges we face in improving patient safety and decreasing healthcare-related harm and death remain urgent, compelling, and undeniable. Despite our considerable efforts over the past 15 years, and some very notable advances, mostly resulting from increased standardization of processes and the use of checklists, the overall magnitude of the problem remains enormous.
By Pat Parks, MD, PhD Healthcare leaders and care providers charged with the difficult task of preventing infections are no strangers to the incredibly unfortunate loss of life and staggering financial burden of healthcare-associated infections (HAI). Some of the deadliest HAIs are central line–associated bloodstream infections (CLABSI) and catheter-related bloodstream infections (CRBSI). According to the … Continued
By John Palmer Train your workers how to use the tools that protect them. One of the first things that a student learns in medical school, one of the first thing a worker learned on the job, and perhaps the most important thing you, as a safety professional can be a pest about with your … Continued
A deadly infection that has lingered throughout healthcare for the last several decades is finding a foothold at the national level thanks to recently updated definitions that offer clinicians a more targeted approach for detection and prevention.
Less-invasive surgeries and new drugs have stanched demand, but more government oversight is needed to safeguard the supply of blood to hospitals.
This October, the Department for Health and Human Services (HHS) announced ambitious, new targets for reducing healthcare-associated infections (HAI) in acute care hospitals, long-term care facilities, and ambulatory surgical centers.
A deadly new drug-resistant fungus has been linked to the deaths of four hospital patients in the U.S., according to a report released Friday from the Centers for Disease Control and Prevention.
The fungus, called Candida auris, preys on the sickest patients and can spread in hospitals.
Amid mounting evidence that contact precautions may not be necessary to prevent the transmission of certain infections, experts are calling for hospitals to reconsider what has been a staple of infection prevention guidelines for decades.